05). And also in the H.pylori positive gastric cancer group, the expression of GSK-3β reduced and phosphorylated GSK-3β rose. Conclusion: Expression of GSK-3β decreased and phosphorylated GSK-3β increased in gastric cancer tissues, especially in H.pylori positive patients. The inactivation of GSK-3β is related to the initiation or progression
of gastric cancer. H.pylori may be involved in the inactivation of GSK-3β. Key Word(s): 1. GSK-3β; 2. gastric cancer; 3. helicobacter pylori; Presenting Author: XU YUAN Additional Authors: TANG WEN Corresponding Author: XU YUAN Affiliations: the second affiliated hospital of soochow university Objective: Proton pump inhibitors Doxorubicin research buy (PPIs) are widely
utilized for the treatment of acid-related disorders. All PPIs suppress gastric acid secretion by blocking the gastric acid pump, H+/K+-adenosine triphosphatase (ATPase). Recent studies have demonstrated that long term and high dose use of PPI increased risks of hip fractures. In this study, we have examined the effects of different doses of esomeprazole use of male rats at different time points. Methods: Twenty four 3-month-old male rats were divided into three groups: the control group received the vehicle only, the low-dose esomeprazole group was treated with esomeprazole of 10 mg/kg●d and the high-dose esomeprazole group Selleckchem Sorafenib was treated with esomeprazole of 50 mg/kg●d. Dual-energy X-ray absorptiometry, enzyme-linked immunosorbent assay and automatic see more chemistry analysis was conducted to assess total
bone mineral densities (BMDs) and bone alkaline phosphatase (B-ALP), tartate resistant acid phosphatase 5b (TRACP 5b) and serum calcium concentration at weeks 0, 8 and 14. Bone histomorphometric analysis was performed to evaluate the structural changes in the femur of rats after sacrifice. Results: The body weight of the high-dose esomeprazole group was suppressed whereas that of the control group increased significantly at week 8. The BMD of the high-dose group decreased dramatically whereas that of the other two groups increased significantly. Serum B-ALP, TRACP 5b and calcium concentrations increased in the high-dose group at week 14. Significant changes in the results were not observed at week 8. Bone histomorphometric analysis showed significantly different bone structures among the three groups. Conclusion: Long term and high dose use of esomeprazole reduces bone mineral density and effects bone metabolism of male rats in a time-dependent manner. Key Word(s): 1. PPIs; 2. bone mineral density; 3. bone metabolism; 4.